HCG is recognized as a ligand of the luteinizing hormone/chorionic gonadotropin receptor (LHCGR), a member of the G protein-coupled receptor (GPCR) superfamily.
The receptor contains a large extracellular domain involved in hormone recognition, together with a transmembrane region associated with intracellular signal transmission. Molecular investigations have examined how the structural features of HCG influence its interaction with these receptor domains.
HCG and LHCGR Binding
HCG interacts with the extracellular region of LHCGR through contacts involving its glycoprotein structure. Receptor-binding investigations have examined the contribution of individual amino-acid residues, subunit arrangement and hormone conformation to molecular recognition.
The HCG/LH structural relationship is of particular relevance to this work. Both hormones bind to LHCGR but the differences in their beta subunits and glycosylation patterns offer the opportunity to look at differences in ligand-receptor interaction.
G Protein and cAMP Signaling
LHCGR is principally associated with Gs-mediated signaling. Receptor activation can promote the activity of adenylyl cyclase, an enzyme involved in the conversion of ATP to cyclic adenosine monophosphate (cAMP).
In biochemical signaling systems, cAMP acts as a second messenger and can regulate downstream proteins, including protein kinase A (PKA).
Laboratory investigations of this pathway may involve receptor-binding measurements, adenylyl cyclase activity assays and quantitative analysis of intracellular cAMP.
Additional Signaling Pathways
Beyond the main Gs/cAMP pathway, research into LHCGR signaling has looked at other molecular pathways including those associated with phospholipase C and the mitogen-activated protein kinase (MAPK) pathway.
ERK1/2 phosphorylation is one example of a measurable biochemical event associated with GPCR signaling investigations.
The relationship between receptor conformation, ligand recognition and downstream signaling remains an area of molecular research. Different experimental conditions and receptor systems can influence the signaling responses recorded.
This summary reflects findings reported in published preclinical and in vitro research. The original studies supporting this information are listed in the references.